Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

CLPT ClearPoint Neuro, Inc. Common Stock
$13.09 -2.39% -0.32
Notify me if price changes either direction
Interactive Brokers Logotype

Buy CLPT stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 387.9M
Enterprise value 377.5M
Trailing PE -18.628571374076
Forward PE -16.161491
PEG Ratio -1.1177142824445
Enterprise to EBITDA -17.191
Enterprise to revenue 10.997
Price to book MRQ 23.31541
Price to sales TTM 11.2730255

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 34.3M
EBITDA -21962000
Diluted EPS TTM -0.83
Total Cash (MRQ) 38.2M
Current ratio (MRQ) 6.374
Operating Cash Flow (TTM) -13088000

CLPT trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent CLPT News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.